Showing results (441-450 of 641) with videos related to
Sort By:
Pageof 65
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.Haematologica|February 12, 2026
Body mass index during and early after therapy for pediatric acute lymphoblastic leukemia is associated with obesity in survivorsKunanya Suwannaying, Grace C Zhou, Nawachai Lertvivatpong, et al.Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.Hepatology (Baltimore, Md.)|July 18, 2018
Serum Alanine Aminotransferase Elevations in Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort StudyDaniel M Green, Mingjuan Wang, Matthew J Krasin, et al.Pediatric Blood & Cancer|May 12, 2018
Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort StudyIsrael Fernandez-Pineda, Andrew M Davidoff, Lu Lu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort studyWassim Chemaitilly, Zhenghong Li, Sujuan Huang, et al.The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2013
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantationMarcos de Lima, David L Porter, Minoo Battiwalla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trialAlan S Wayne, Robert J Kreitman, Harry W Findley, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotoxFabian Müller, Tyler Cunningham, Stephanie Stookey, et al.Pageof 65